human | Q5 |
P9843 | IRIS UNINA author ID | 01720 |
P496 | ORCID iD | 0000-0003-1493-5133 |
P1153 | Scopus author ID | 6603590758 |
P734 | family name | Salvatore | Q37477337 |
Salvatore | Q37477337 | ||
Salvatore | Q37477337 | ||
P735 | given name | Elena | Q1209486 |
Elena | Q1209486 | ||
P106 | occupation | researcher | Q1650915 |
P21 | sex or gender | female | Q6581072 |
Q43164753 | Atorvastatin combined to interferon to verify the efficacy (ACTIVE) in relapsing-remitting active multiple sclerosis patients: a longitudinal controlled trial of combination therapy |
Q46177064 | Autonomic nervous system abnormalities in spinocerebellar ataxia type 2: a cardiovascular neurophysiologic study. |
Q82719745 | Axial diffusivity is increased in the degenerating superior cerebellar peduncles of Friedreich's ataxia |
Q42472823 | Benign hereditary chorea: clinical and neuroimaging features in an Italian family. |
Q48103327 | Brain structural damage in Friedreich's ataxia. |
Q80800919 | Brain structural damage in spinocerebellar ataxia type 2. A voxel-based morphometry study |
Q48383738 | Brain tissue volume changes in relapsing-remitting multiple sclerosis: correlation with lesion load |
Q49019706 | Brain white matter damage in SCA1 and SCA2. An in vivo study using voxel-based morphometry, histogram analysis of mean diffusivity and tract-based spatial statistics |
Q46786933 | Brain white matter tracts degeneration in Friedreich ataxia. An in vivo MRI study using tract-based spatial statistics and voxel-based morphometry. |
Q46987572 | Characterization of nigrostriatal dysfunction in spinocerebellar ataxia 17. |
Q34584948 | Chronic cerebrospinal venous insufficiency in multiple sclerosis: a highly prevalent age-dependent phenomenon. |
Q84592634 | Combining beta interferon and atorvastatin may increase disease activity in multiple sclerosis |
Q43405175 | Cortical sources of resting state EEG rhythms are sensitive to the progression of early stage Alzheimer's disease. |
Q45028881 | Cortical sources of resting state electroencephalographic alpha rhythms deteriorate across time in subjects with amnesic mild cognitive impairment |
Q34973519 | Default-mode network changes in Huntington's disease: an integrated MRI study of functional connectivity and morphometry |
Q48310729 | Depression comorbidity in spinocerebellar ataxia |
Q45299922 | Growth hormone response to arginine test differentiates between two subgroups of Huntington's disease patients |
Q48300081 | Identification by [99mTc]ECD SPECT of anterior cingulate hypoperfusion in progressive supranuclear palsy, in comparison with Parkinson's disease |
Q37124915 | In vivo imaging of neurotransmission and brain receptors in dementia. |
Q30440971 | Internal jugular vein blood flow in multiple sclerosis patients and matched controls |
Q48716887 | Is anterior communicating artery syndrome related to fornix lesions? |
Q84365795 | Neurodegeneration in friedreich's ataxia is associated with a mixed activation pattern of the brain. A fMRI study |
Q55044604 | Neuroimaging follow-up in a case of Rasmussen's encephalitis with dyskinesias. |
Q42683605 | Neuropsychological assessment, quantitative MRI and ApoE gene polymorphisms in a series of MS patients treated with IFN beta-1b. |
Q57243918 | PINK1 homozygous W437X mutation in a patient with apparent dominant transmission of parkinsonism |
Q35107256 | Progression of brain atrophy in spinocerebellar ataxia type 2: a longitudinal tensor-based morphometry study |
Q48225984 | Progression of microstructural damage in spinocerebellar ataxia type 2: a longitudinal DTI study. |
Q44443293 | Resting state cortical electroencephalographic rhythms and white matter vascular lesions in subjects with Alzheimer's disease: an Italian multicenter study |
Q43696898 | Stimulation of growth hormone release in multiple system atrophy, Parkinson's disease and idiopathic cerebellar ataxia. |
Q50859262 | The Italian Alzheimer's Disease Neuroimaging Initiative (I-ADNI): validation of structural MR imaging. |
Q48014661 | Two novel CYP7B1 mutations in Italian families with SPG5: a clinical and genetic study. |
Q45302043 | Whole body cholesterol metabolism is impaired in Huntington's disease. |
Search more.